Rhabdomyolysis secondary to COVID-19 vaccination: case report
DOI:
https://doi.org/10.32385/rpmgf.v39i1.13545Keywords:
Rhabdomyolysis, Vaccine, COVID-19Abstract
Introduction: Rhabdomyolysis is characterized by skeletal muscle injury. It has been described as a complication of COVID-19 infection, but few cases associated with COVID-19 vaccination have been reported.
Case report: After the hospital discharge of an 80-year-old female patient, the family doctor received the admission report for pain and weakness in her lower limbs. Common causes of rhabdomyolysis were excluded; however, it is noteworthy that she had been given the first dose of the vaccine against COVID-19 (Vaxzevria®) one day prior to admission. After management, the symptoms improved, and she was discharged. After a complete evaluation, the patient was found to have vaccine-related rhabdomyolysis, becoming one of the first cases of rhabdomyolysis following an adenoviral vector-based vaccine for COVID-19.
Comment: Physicians should be aware of the possibility of COVID-19 vaccine-induced rhabdomyolysis as a potentially serious side-effect in patients with myalgia, weakness, and dark urine. Nonetheless, the benefit-risk assessment shows a favorable balance.
Downloads
References
Zimmerman J, Shen MC. Rhabdomyolysis. Chest. 2013;144(3):1058-65.
Ajmera KM. Fatal case of rhabdomyolysis post-COVID-19 vaccine. Infect Drug Resist. 2021;14:3929-35.
Fragkou PC, Dimopoulou D. Serious complications of COVID-19 vaccines: a mini-review. Metabol Open. 2021;12:100145.
Khosla SG, Nylen ES, Khosla R. Rhabdomyolysis in patients hospitalized with COVID-19 infection: five case series. J Investig Med High Impact Case Rep. 2020;8:2324709620984603.
Nassar M, Chung H, Dhayaparan Y, Nyein A, Acevedo BJ, Chicos C, et al. COVID-19 vaccine induced rhabdomyolysis: case report with literature review. Diabetes Metab Syndr. 2021;15(4):102170.
Haroun MW, Dieiev V, Kang J, Barbi M, Nia SF, Gabr M, et al. Rhabdomyolysis in COVID-19 patients: a retrospective observational study. Cureus. 2021;13(1):e12552.
Mack M, Nichols L, Guerrero DM. Rhabdomyolysis secondary to COVID-19 vaccination. Cureus. 2021;13(5):e15004.
Rajaratnam N, Govil S, Patel R, Ahmed M, Elias S. Rhabdomyolysis after recombinant zoster vaccination: a rare adverse reaction. J Community Hosp Intern Med Perspect. 2021;11(1):145-6.
Gelbenegger G, Cacioppo F, Firbas C, Jilma B. Rhabdomyolysis following Ad26.COV2.S COVID-19 vaccination. Vaccines. 2021;9(9):956.
Edwards KM, Orenstein WA. COVID-19: vaccines. In: UpToDate [Internet]; 2022 [updated 2022 Dec; cited 2022 Oct 6]. Available from: https://www.uptodate.com/contents/covid-19-vaccines
Deng L, Glover C, Dymock M, Pillsbury A, Marsh JA, Quinn HE, et al. The short term safety of COVID‐19 vaccines in Australia: AusVaxSafety active surveillance, February – August 2021. Med J Aust. 2022;217(4):195-202.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Portuguese Journal of Family Medicine and General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
